Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies

Rationale: Messenger RNA (mRNA) vaccine outperforms other kinds of cancer immunotherapy due to its high response rates, easy preparation, and wide applicability, which is considered as one of the most promising forms of next-generation cancer therapies. However, the inherent instability and insuffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongjian, Peng, Kun, Yang, Kai, Ma, Wenbo, Qi, Shaolong, Yu, Xinyang, He, Jia, Lin, Xin, Yu, Guocan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475446/
https://www.ncbi.nlm.nih.gov/pubmed/36168634
http://dx.doi.org/10.7150/thno.77350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475446/
https://www.ncbi.nlm.nih.gov/pubmed/36168634
http://dx.doi.org/10.7150/thno.77350

Ejemplares similares